Surgeon Erie County Medical Center Buffalo, New York
Disclosure: Nothing to disclose.
An estimated more than 25 million Americans have obstructive sleep apnea. The gold standard is considered continuous positive pressure therapy (CPAP). A large percentage of patients are unable to tolerate CPAP, and alternative therapies are needed. The Inspire hypoglossal nerve stimulator is the only FDA-approved implantable device that has been proven in clinical trial to significantly improve OSA and alleviate the need for CPAP. This session is designed to provide insight into the Inspire device, how it works and the surgical placement technique.
Learning Objectives:
At the conclusion of this presentation, participants should be able to:
Define obstructive sleep apnea and the requirements for hypoglossal nerve stimulation therapy.
List the risks, benefits and alternatives to treatment with hypoglossal nerve stimulation.
Describe the requirements for candidacy for hypoglossal nerve stimulation therapy.
Cite the surgical steps in placement of the hypoglossal nerve stimulation device.
Review the anatomy of the hypoglossal nerve and the importance of determining the functional break point.